Sutent (sunitinib malate capsules - Pfizer; generic) — Cigna
Thyroid Carcinoma, Differentiated
Initial criteria
- Patient age ≥ 18 years
- Patient has papillary or follicular thyroid carcinoma refractory to radioactive iodine therapy OR patient has oncocytic (formerly Hürthle cell) carcinoma
Approval duration
1 year